Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

Full text not available from this repository.

Item Type:	Article
Authors :	Name Email ORCID Roulstone, V UNSPECIFIED UNSPECIFIED Khan, K UNSPECIFIED UNSPECIFIED Pandha, HS h.pandha@surrey.ac.uk UNSPECIFIED Rudman, S UNSPECIFIED UNSPECIFIED Coffey, M UNSPECIFIED UNSPECIFIED Gill, GM UNSPECIFIED UNSPECIFIED Melcher, AA UNSPECIFIED UNSPECIFIED Vile, R UNSPECIFIED UNSPECIFIED Harrington, KJ UNSPECIFIED UNSPECIFIED de Bono, J UNSPECIFIED UNSPECIFIED Spicer, J UNSPECIFIED UNSPECIFIED
Date :	15 March 2015
Identification Number :	https://doi.org/10.1158/1078-0432.CCR-14-1770
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology, ADVANCED CANCER, TYPE-3, CHEMOTHERAPY, CYCLOSPORINE, COMBINATION, EFFICACY, THERAPY, INNATE, I/II
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 10:27
Last Modified :	17 May 2017 14:49
URI:	http://epubs.surrey.ac.uk/id/eprint/827834

Actions (login required)

View Item

Downloads